CVS Health (CVS) to Release Quarterly Earnings on Wednesday

CVS Health (NYSE:CVS - Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Analysts expect the company to announce earnings of $1.69 per share for the quarter. Parties that are interested in participating in the company's conference call can do so using this link.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.11. The firm had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The business's revenue was up 11.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.99 earnings per share. On average, analysts expect CVS Health to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

CVS Health Stock Performance

Shares of CVS stock traded down $0.74 during trading on Wednesday, reaching $67.76. 8,650,023 shares of the company's stock traded hands, compared to its average volume of 10,731,002. The company has a market capitalization of $85.41 billion, a P/E ratio of 10.49, a PEG ratio of 0.92 and a beta of 0.52. CVS Health has a 1 year low of $64.41 and a 1 year high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The firm's 50-day moving average is $74.80 and its 200 day moving average is $73.72.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.93%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health's payout ratio is 41.18%.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. SVB Leerink initiated coverage on shares of CVS Health in a research report on Monday, February 26th. They set an "outperform" rating and a $88.00 price target on the stock. Leerink Partnrs reaffirmed an "outperform" rating on shares of CVS Health in a report on Monday, February 26th. Royal Bank of Canada lowered their target price on CVS Health from $86.00 to $84.00 and set an "outperform" rating on the stock in a research report on Thursday, February 8th. Piper Sandler boosted their target price on shares of CVS Health from $93.00 to $94.00 and gave the stock an "overweight" rating in a report on Friday, March 15th. Finally, StockNews.com lowered CVS Health from a "buy" rating to a "hold" rating in a research note on Thursday, February 15th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $89.44.

Insider Activity

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the business's stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares of the company's stock, valued at approximately $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.24% of the company's stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.